Comparison

Vaccarin European Partner

Item no. TMO-T3881-1mg
Manufacturer TargetMol
CASRN 53452-16-7
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 20 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,999
Citations 1. Xie F,et al. Vaccarin promotes endothelial cell proliferation in association with neovascularization in vitro and in vivo. Mol Med Rep. 2015 Jul;12(1):1131-6.
Smiles OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2cc(=O)c3c(O)c([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4OC[C@H](O)[C@H](O)[C@H]4O)c(O)cc3o2)[C@H](O)[C@@H](O)[C@@H]1O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Akt activator,ERK,Integrin
Shipping Condition Cool pack
Available
Manufacturer - Targets
Akt|||PERK|||AMPK|||Integrin
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
726.63
Description
Vaccarin is a major flavonoid glycoside in Vaccariae semen, its biotransformation pathways involves methylation, hydroxylation, glycosylation and deglycosylation.
Pathways
Apoptosis|||Cytoskeletal Signaling|||PI3K/Akt/mTOR signaling|||Chromatin/Epigenetic
Bioactivity
Vaccarin is a major flavonoid glycoside in Vaccariae semen, its biotransformation pathways involves methylation, hydroxylation, glycosylation and deglycosylation.
Receptor
P-Akt; PERK; CD31

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close